PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $220,916,161.58 |
| Submission deadline | Deadline not published |
| Published | Sep 27, 2022 |
| Buyer | Office of Assistant Secretary for Preparedness and Response |
| Country | United States · CA |
| CPV code | NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC 6505 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $220,916,161.58
- Submission deadline
- Deadline not published
- Published
- Sep 27, 2022
- Country
- United States
- CPV code
- NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTEC) · PSC 6505
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| MAPP BIOPHARMACEUTICAL, INC. | US-UEI: M9V9QTHR1H28 | United States | $220,916,161.58 | Sep 27, 2022 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Awarding Agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response.
NAICS 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY).
PSC 6505: DRUGS AND BIOLOGICALS.
Period of Performance: 2022-09-30 to 2030-09-30.